(Q43919582)

28 November 2017

title

Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). (English)

1 reference

28 November 2017

0 references

1 reference

coronary artery disease

1 reference

5

Paul J Lupien

1 reference

28 November 2017

Bernard Cantin

1

1 reference

28 November 2017

Jean Pierre Després

2

1 reference

28 November 2017

Benoît Lamarche

3

1 reference

28 November 2017

Sital Moorjani

4

1 reference

28 November 2017

Peter Bogaty

6

1 reference

28 November 2017

Jean Bergeron

7

1 reference

28 November 2017

Gilles R Dagenais

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

American Journal of Cardiology

28 November 2017

published in

1 reference

28 November 2017

volume

89

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

662-666

1 reference

Haemostatic function and cardiovascular death: early results of a prospective study

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

The role of fibrinogen as a cardiovascular risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: The Caerphilly and Speedwell Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Apolipoproteins and ischaemic heart disease: implications for screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

A prospective study of lipoprotein(a) and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

[Rapid physiological coagulation method in determination of fibrinogen]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Fate of fibrinogen in human arterial intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

The possible role of hemorheology in atherothrombogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Fibrinogen as a major risk factor in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902336-0

10.1016/S0002-9149(01)02336-0

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference